FDA to Appoint Biotech Executive as RFK Jr.'s Top Drug Regulator
Bloomberg.comarrow_outwardFDA to appoint former biotech executive Tidmarsh as top drug regulator, Bloomberg News reports
Yahoo.coarrow_outwardFDA names former industry exec Tidmarsh as next CDER director
Endpoints Newsarrow_outwardFDA to appoint George Tidmarsh as top drug regulator, Bloomberg News reports By Reuters - Investing.com
Investing.comarrow_outwardFDA to appoint George Tidmarsh as top drug regulator, Bloomberg News reports - MarketScreener
MarketScreenerarrow_outwardFDA to appoint former biotech executive Tidmarsh as top drug regulator, Bloomberg News reports - Yahoo Home
Yahoo Homearrow_outwardFDA to appoint former biotech executive Tidmarsh as top drug regulator, Bloomberg News reports - Colorado Springs Gazette
Colorado Springs Gazettearrow_outwardFDA to Appoint George Tidmarsh as Top Drug Regulator, Bloomberg News Reports - U.S. News & World Report
U.S. News & World Reportarrow_outwardFDA’s Makary selects biotech veteran Tidmarsh as top drug regulator By Investing.com - Investing.com South Africa
Investing.com South Africaarrow_outwardFDA Declared Talc Safe in the 1970s, Never Reexamined It - RealClearHealth
RealClearHealtharrow_outwardDr. George Tidmarsh: FDA Declared Substances Like Talc Were Safe In The 1970s, Never Reexamined Them - Real Clear Politics
Real Clear Politicsarrow_outwardThis 'probably toxic' ingredient is in 4 of the most-prescribed drugs—and the FDA may soon outlaw it - MDLinx
MDLinxarrow_outwardMakary's Jefferies appearance tempers biotech fears - Axios
Axiosarrow_outwardRevelation Biosciences: Is It Set To Recover? - StocksToTrade
StocksToTradearrow_outwardRevelation Biosciences Board Member Resigns Amid New Role - TipRanks
TipRanksarrow_outwardRevelation Biosciences Announces Retirement of George Tidmarsh, MD, PhD from Board of Directors - Business Wire
Business Wirearrow_outwardFDA targets talc in food and medicine - C&EN
C&ENarrow_outwardThe WaPo Engages in Fear-Mongering About NIH - RealClearPolicy
RealClearPolicyarrow_outwardNews, Politics, Sports, Mail & Latest Headlines - AOL.com
AOL.comarrow_outwardNew journal co-founded by NIH nominee raises eyebrows, misinformation fears - Science | AAAS
Science | AAASarrow_outwardTrump administration to keep only 294 USAID staff out of over 10,000 globally, sources say - Reuters
Reutersarrow_outwardIntroducing the Retraction Watch Sleuth in Residence Program - Retraction Watch
Retraction Watcharrow_outwardRuby Thompson death: Woman who murdered baby she wanted to adopt jailed - BBC
BBCarrow_outwardMotivational Monday: Staying Motivated Once Your 'Glory Days' Have Passed Through Open Water - Swimming World
Swimming Worldarrow_outwardInnoviva snaps up La Jolla and its 2 FDA-approved drugs for $149M - Fierce Pharma
Fierce Pharmaarrow_outwardIntroducing the New M-TRAM Program - Stanford University
Stanford Universityarrow_outwardREVB - Revelation Biosciences Latest Stock News & Market Updates - Stock Titan
Stock Titanarrow_outwardAir France-KLM Partners with Sea Chefs Cruises to Develop Sustainable Fuel Industry - GTP Headlines
GTP Headlinesarrow_outwardAngiotensin converting enzyme defects in shock: implications for future therapy - BioMed Central
BioMed Centralarrow_outwardThe story behind big pay days, and will Trump’s tax cut impact CEO compensation? - San Diego Union-Tribune
San Diego Union-Tribunearrow_outwardTable 4 . Study drug titration schema - researchgate.net
Researchgate.netarrow_outwardLa Jolla surges on Phase 3 results for shock patients - BioPharma Dive
BioPharma Divearrow_outwardUS scrambles to ease shortage of vital medicines - NBC News
NBC Newsarrow_outward
George Tidmarsh close
- 2025-07-21 19:40 event
- 33 sourceslanguage
- 200+ ads_click
- 2 months ago schedule